With a background in pharmacology and toxicology, Jane Myles has spent her career in drug development at pharma/ biotech companies and startups promoting patient-centric approaches, raising awareness, and supporting the adoption of patient-focused clinical research. For more than 25 years, she has also lived with dermatomyositis, an experience that has anchored her passion and brought true meaning to her work. She comes to TMA with a mission to amplify the patient’s voice and support the development of groundbreaking diagnostics and treatments.